臨床(前)試驗應用廣泛，適應症如：腦神經相關退化性疾病、腦/心血管疾病、呼吸系統疾病、肝臟/腎臟/胰臟損傷、皮膚缺陷、軟骨受損、黃斑部病變等。
相關報導：https://www.mohw.gov.tw/cp-4630-54763-1.html
參考資料：
1. Kan Yin et al. Biomark Res 7, 8 (2019).
2. Tingfen Li et al. STEM CELLS AND DEVELOPMENT Volume 22. Number (2013).
3. Stefania Bruno et al. J Am Soc Nephrol 20: 1053–1067. (2009).
4. Xiaojun Cui et al. J Cardiovasc Pharmacol. Volume 70, Number 4. October (2017).
5. Changchen Xiao et al. Circulation Research. August (2018).
6. Hongqi Xin et al. Stroke.48(5):e137. May (2017).
7. Guo-Hong Cui et al. FASEB J. 32(2):654-668. Feb (2018).
8. Peilong Lai et al. J Hematol Oncol 11, 135. (2018).
9. Taeko Shigemoto-Kuroda et al. Stem Cell Reports. 8(5): 1214–1225. May (2017).
10. Zhang et al, Cell Transplantation(2020).